[1]
Nalli, C. et al. 2011. Fine specificity of anti-beta2glycoprotein I antibodies in systemic autoimmune diseases is mostly directed against domain 1. Reumatismo. 63, 2 (Jun. 2011), 91–96. DOI:https://doi.org/10.4081/reumatismo.2011.91.